Intraventricular immunovirotherapy: A translational step forward
A new research perspective titled "Intraventricular immunovirotherapy; a translational step forward" has been published in Oncotarget.
Jan 26, 2023
0
5
A new research perspective titled "Intraventricular immunovirotherapy; a translational step forward" has been published in Oncotarget.
Jan 26, 2023
0
5
Sometimes hospital staff nurses cannot provide required care due to time constraints. This reality can contribute to potentially dire outcomes for very low birthweight (VLBW) infants, who weigh less than 3.3 lbs. at birth.
Jan 24, 2023
0
23
It's a good news, bad news story. Patients whose brain tumors have a mutated enzyme called IDH1 typically live longer than those without the mutation. But even as these tumors are initially less aggressive, they always come ...
Jan 24, 2023
0
19
Traumatic brain injury is a leading cause of epilepsy, a chronic neurological disorder characterized by recurrent seizures that affects around 50 million people. A research team led by Bret Smith, professor and head of the ...
Jan 24, 2023
0
11
A University of Alberta researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases.
Jan 24, 2023
0
1017
In patients with Huntington's disease, neurons in a part of the brain called the striatum are among the hardest-hit. Degeneration of these neurons contributes to patients' loss of motor control, which is one of the major ...
Jan 20, 2023
0
54
The neocortex is the largest and most complex part of the brain and has long been recognized as the ultimate storage site for memories. But how are traces of past events and experiences laid down there? Scientists at the ...
Jan 9, 2023
0
171
The BRAIN-AI initiative, a fusion of artificial intelligence and neuroscience research by the JST ERATO Ikegaya Brain-AI Fusion Project, has the potential to break through existing limitations on brain activity and expand ...
Jan 5, 2023
0
5
A rapidly growing body of evidence shows the importance and effectiveness of cognitive rehabilitation for individuals with traumatic brain injury (TBI). A major update of the groundbreaking INCOG guidelines for cognitive ...
Jan 3, 2023
0
3
A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers. The drug stalled the growth of tumors in the five people in the ...
Dec 22, 2022
0
28